+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Carboxy Therapy Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

  • PDF Icon

    Report

  • 178 Pages
  • October 2023
  • Region: Global
  • TechSci Research
  • ID: 5895985
Free Webex Call
10% Free customization

The Hospitals Segment is Experiencing the Fastest Growth, with North America Emerging as the Largest Regional Market

Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

The Carboxy Therapy market was valued at USD 70.18 million in 2022, and is poised for remarkable growth with a CAGR Of 9.16% by 2028. This surge can be attributed to the increasing awareness among both physicians and patients about the therapeutic benefits offered by carboxy therapy units. Moreover, the proliferation of technological advancements has paved the way for surgical approaches that optimize resources, minimize wastage, and yield enhanced outcomes, thereby driving profitable expansion throughout the forecast period. Additionally, the escalating demand for carboxy therapy is buoyed by the growing geriatric population and a heightened pursuit of aesthetic enhancement on a global scale. For instance, in 2020, the International Society of Aesthetic Plastic Surgery (ISAPS) global survey reported 14,400,347 nonsurgical procedures conducted worldwide.

Growing Demand for Non-Invasive Cosmetic Procedures

A pivotal driver behind the growth of the global carboxy therapy market is the surging demand for non-invasive cosmetic procedures. The escalating inclination towards non-invasive cosmetic interventions has naturally translated to an increased demand for carboxy therapy. This treatment modality, being non-invasive, holds the potential to enhance skin appearance and mitigate signs of aging. As the demand for non-invasive solutions surges, carboxy therapy gains traction due to its positive attributes. The growing clamor for non-invasive cosmetic treatments has also catalyzed technological advancements, leading to enhanced efficacy and accessibility of carboxy therapy. This technological progress not only makes carboxy therapy more effective but also appeals to those previously hesitant to explore this avenue. The proliferation of non-invasive cosmetic procedures spawns a corresponding demand surge for treatments like carboxy therapy, renowned for its minimal invasiveness and short recovery periods.

Rising Awareness of Carboxy Therapy Benefits

The expanding awareness about the benefits of carboxy therapy holds significant sway in propelling the global carboxy therapy market's expansion. As more individuals become cognizant of the advantages offered by carboxy therapy, the demand for this treatment modality rises. Carboxy therapy's non-invasive nature, capable of enhancing skin appearance and diminishing signs of aging, increasingly resonates with individuals seeking aesthetic improvements. Positive experiences with carboxy therapy often lead to word-of-mouth endorsements, heightening general awareness about this treatment, and fostering a greater uptake. This growing awareness translates to a surge in demand, consequently prompting more clinics and practitioners to offer carboxy therapy, thereby amplifying its accessibility. This escalating awareness about the merits of carboxy therapy is also serving as a catalyst for innovation, as researchers and manufacturers strive to refine administration techniques, enhancing both effectiveness and efficiency. This growing awareness in turn drives the demand for a broader range of applications for carboxy therapy, such as weight loss and cellulite reduction.

Escalating Prevalence of Skin-Related Conditions

The rising incidence of skin-related conditions is a notable factor influencing the growth trajectory of the global carboxy therapy market. Skin ailments like acne, wrinkles, fine lines, and scars are increasingly prevalent, driving the demand for effective treatments to address these concerns. Carboxy therapy, proven to be efficacious in treating various skin-related conditions, is witnessing a surge in demand as a result. The mounting prevalence of such conditions has also engendered heightened awareness about the efficacy of carboxy therapy in their treatment. Informed individuals seeking effective solutions are more inclined to explore carboxy therapy as a viable option. As the prevalence of skin-related conditions continues to rise, the demand for treatment options intensifies. This growing demand in turn fuels innovation within the realm of carboxy therapy, spurring research and development efforts to enhance its applicability across a broader spectrum of skin-related issues. As the market for skin treatments becomes increasingly competitive, carboxy therapy's popularity and effectiveness ensure its prominence within this dynamic landscape.

Technological Advancements

Significant technological advancements are wielding a notable impact on the growth of the global carboxy therapy market. These advancements have facilitated the development of refined delivery systems for carboxy therapy, optimizing gas administration for more precise and effective treatments. Progressing technology is also yielding novel applications for carboxy therapy, such as addressing hair loss and dark circles under the eyes. Enhanced technology translates to increased comfort during treatment, exemplified by the introduction of needle-free carboxy therapy, negating the need for needles and minimizing discomfort. These technological strides concurrently enhance the safety of carboxy therapy, reducing the risk of complications and side effects, thereby bolstering patient safety. The continuous advancement of technology broadens the accessibility of carboxy therapy, streamlining delivery and enhancing efficacy, enabling practitioners to cater to a larger patient base within a shorter timeframe.

Increasing Availability of Healthcare Facilities Offering Carboxy Therapy

The burgeoning number of healthcare facilities providing carboxy therapy is a compelling factor shaping the expansion of the global carboxy therapy market. This growing availability renders carboxy therapy more accessible to a diverse patient population, catalyzing demand and driving market growth. The broader accessibility also contributes to heightened patient awareness, exposing individuals to the treatment who may have been previously unfamiliar with it. This exposure subsequently elevates demand, propelling market expansion. The increasing prevalence of carboxy therapy across healthcare facilities not only amplifies its reach but also elevates the quality of care delivered to patients. Treatment within a medical setting enhances safety and minimizes the likelihood of complications. Healthcare facilities benefit from diversifying their revenue streams, a factor that fosters financial stability and sustains investments in carboxy therapy, ultimately driving market growth.

Market Segmentation

Global Carboxy Therapy market can be segmented by type, application, end users and by region. Based on the type, the market can be segmented into Tabletop, Portable, Others. Based on application, the market can be segmented into Tabletop, Portable, Others. Based on end users, the market can be differentiated into Hospitals, Aesthetic Clinics, Wellness Centers.

Market Players

DTA Medical., Fosun Pharmaceutical Co., Ltd., Merz Pharma GmbH & Co. KGaA., Cosmo Pro Ltd., Allergan plc., Carbossiterapia Italiana., Beijing Jontelaser Technologies Co. Ltd., Kastner-Praxisbedarf., Mezopharma., MBE Medical Division., Nick Fanavaran Plasma Company., Alvi Prague., and JONTE are some of the leading players operating in the global carboxy therapy market.

Report Scope

In this report, Global Carboxy Therapy market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Carboxy Therapy Market, by Type:

  • Tabletop
  • Portable
  • Other Instruments

Carboxy Therapy Market, by Application:

  • Aesthetic Medicine
  • Dermatology
  • Gynaecology
  • Angiology
  • Orthopaedic & Rheumatology
  • Sports Medicine
  • Others Clinical Diagnosis

Carboxy Therapy Market, by End Users:

  • Hospitals
  • Aesthetic Clinics
  • Wellness Centers

Carboxy Therapy Market, by Region:

  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Carboxy Therapy Market.

Available Customization

The following customization option is available based on your specific needs: Detailed analysis and profiling of additional market players (up to five).


This product will be delivered within 1-3 business days.

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Carboxy Therapy Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Tabletop, Portable, Others)
5.2.2. By Application (Aesthetic Medicine, Dermatology, Gynaecology, Angiology, Orthopaedic & Rheumatology, Sports Medicine, Others)
5.2.3. By End Users (Hospitals, Aesthetic Clinics, Wellness Centers)
5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
5.2.5. By Company (2022)
5.3. Market Map
5.3.1 By Type
5.3.2 By Application
5.3.3 By End Users
5.3.4 By Region
6. North America Carboxy Therapy Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type (Tabletop, Portable, Others)
6.2.2. By Application (Aesthetic Medicine, Dermatology, Gynaecology, Angiology, Orthopaedic & Rheumatology, Sports Medicine, Others)
6.2.3. By End Users (Hospitals, Aesthetic Clinics, Wellness Centers)
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Carboxy Therapy Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By Application
6.3.1.2.3. By End User
6.3.2. Canada Carboxy Therapy Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By Application
6.3.2.2.3. By End User
6.3.3. Mexico Carboxy Therapy Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By Application
6.3.3.2.3. By End User
7. Europe Carboxy Therapy Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type (Tabletop, Portable, Others)
7.2.2. By Application (Aesthetic Medicine, Dermatology, Gynaecology, Angiology, Orthopaedic & Rheumatology, Sports Medicine, Others)
7.2.3. By End Users (Hospitals, Aesthetic Clinics, Wellness Centers)
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. France Carboxy Therapy Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Application
7.3.1.2.3. By End User
7.3.2. Germany Carboxy Therapy Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Application
7.3.2.2.3. By End User
7.3.3. United Kingdom Carboxy Therapy Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Application
7.3.3.2.3. By End User
7.3.4. Italy Carboxy Therapy Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By Application
7.3.4.2.3. By End User
7.3.5. Spain Carboxy Therapy Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By Application
7.3.5.2.3. By End User
8. Asia-Pacific Carboxy Therapy Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type (Tabletop, Portable, Others)
8.2.2. By Application (Aesthetic Medicine, Dermatology, Gynaecology, Angiology, Orthopaedic & Rheumatology, Sports Medicine, Others)
8.2.3. By End Users (Hospitals, Aesthetic Clinics, Wellness Centers)
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Carboxy Therapy Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Application
8.3.1.2.3. By End User
8.3.2. India Carboxy Therapy Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Application
8.3.2.2.3. By End User
8.3.3. Japan Carboxy Therapy Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Application
8.3.3.2.3. By End User
8.3.4. South Korea Carboxy Therapy Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By Application
8.3.4.2.3. By End User
8.3.5. Australia Carboxy Therapy Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type of Containers
8.3.5.2.2. By Application
8.3.5.2.3. By End User
9. South America Carboxy Therapy Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type (Tabletop, Portable, Others)
9.2.2. By Application (Aesthetic Medicine, Dermatology, Gynaecology, Angiology, Orthopaedic & Rheumatology, Sports Medicine, Others)
9.2.3. By End Users (Hospitals, Aesthetic Clinics, Wellness Centers)
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Carboxy Therapy Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Application
9.3.1.2.3. By End User
9.3.2. Argentina Carboxy Therapy Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Application
9.3.2.2.3. By End User
9.3.3. Colombia Carboxy Therapy Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Application
9.3.3.2.3. By End User
10. Middle East and Africa Carboxy Therapy Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type (Tabletop, Portable, Others)
10.2.2. By Application (Aesthetic Medicine, Dermatology, Gynaecology, Angiology, Orthopaedic & Rheumatology, Sports Medicine, Others)
10.2.3. By End Users (Hospitals, Aesthetic Clinics, Wellness Centers)
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Carboxy Therapy Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By Application
10.3.1.2.3. By End User
10.3.2. Saudi Arabia Carboxy Therapy Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By Application
10.3.2.2.3. By End User
10.3.3. UAE Carboxy Therapy Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.2. By Application
10.3.3.2.3. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches
13. Global Carboxy Therapy Market: SWOT Analysis
14. Porter’s Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Business Overview
15.2. Product Offerings
15.3. Recent Developments
15.4. Financials (As Reported)
15.5. Key Personnel
15.6. SWOT Analysis
15.6.1 DTA Medical.
15.6.2 Fosun Pharmaceutical Co., Ltd.
15.6.3 Merz Pharma GmbH & Co. KGaA.
15.6.4 Cosmo Pro Ltd.
15.6.5 Allergan plc.
15.6.6 Carbossiterapia Italiana.
15.6.7 Beijing Jontelaser Technologies Co. Ltd.
15.6.8 Kastner-Praxisbedarf.
15.6.9 Mezopharma.
15.6.10 MBE Medical Division.
15.6.11 Nick Fanavaran Plasma Company.
15.6.12 Alvi Prague.
15.6.13 JONTE.
16. Strategic Recommendations

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • DTA Medical.
  • Fosun Pharmaceutical Co. Ltd.
  • Merz Pharma GmbH & Co. KGaA.
  • Cosmo Pro Ltd.
  • Allergan PLC.
  • Carbossiterapia Italiana.
  • Beijing Jontelaser Technologies Co. Ltd.
  • Kastner-Praxisbedarf.
  • Mezopharma.
  • MBE Medical Division.
  • Nick Fanavaran Plasma Company.
  • Alvi Prague.
  • JONTE.

Table Information